Developmental Research Program

发展研究计划

• 批准号: 8556458
• 负责人: VERNON K. SONDAK
• 金额: $ 5.64万
• 依托单位: H. LEE MOFFITT CANCER CTR & RES INST
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-20 至 2018-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8556458
• 关键词: Applied Research; Award; Basic Science; Collaborations; Cutaneous; Development; Evaluation; Florida; Funding; Goals; Grant; Institution; Lead; Leadership; Link; Lung; Malignant Neoplasms; Mentors; Modeling; Oncology; Peer Review; Pilot Projects; Prevention; Principal Investigator; Process; Program Research Project Grants; Research; Research Personnel; Skin; Skin Cancer; Study Section; Surgical Oncologist; System; Training; United States National Institutes of Health; base; data quality; expectation; innovation; meetings; member; programs; success

This Developmental Research Program (DRP) will promote the exploration of innovative ideas in translational cutaneous malignancy research through the funding of pilot projects proposed by Moffitt investigators; it will not support extensions of existing full projects. Dr. Vernon Sondak will lead the DRP. He has been a member of NCI Subcommittee G (training grants) and was the Principal Investigator of the first Pre-SPORE grant awarded by the State of Florida. He has mentored dozens of surgical oncologists and is known as an outstanding mentor. To maximize the likelihood that funded projects will be able to serve as replacement projects if needed, the DRP will support the establishment of new collaborations as well as facilitate either a talented investigator in another relevant field, i.e. a new investigator to cutaneous oncology, to become involved in cutaneous malignancy research or promote promising early research by an investigator already established in the cutaneous malignancy field. An innovative feature of the DRP is that investigators will be encouraged to propose projects that, while based at Moffitt, might involve a collaboration with an established Skin SPORE project at another Skin SPORE institution, or with the existing Moffitt Lung SPORE. In collaboration with the Moffitt Lung SPORE, up to one DRP award per year will be co-supported by the Skin SPORE as a cross-SPORE interaction. DRP projects that link to an ongoing Moffitt Skin SPORE project are encouraged. The DRP will provide guidance, advice, evaluation, and funding for up to three pilot projects per year. The goal for each pilot project is to generate sufficient high-quality data in the field of cutaneous malignancy prevention, treatment, basic research, or applied research to allow for submission of an independent project to the NIH or other federal agency for peer review funding. In addition, developmental projects could serve as potential replacement projects elevated to full project status if an existing full project is completed or fails to meet its translational goals and expectations as determined by the Skin SPORE External Advisory Board (EAB) in conjunction with the leadership of this Skin SPORE. The selection of DRP projects for funding by the Award Evaluation Committee (AEC) will be modeled after the NIH study section review process. The AEC will be chaired Dr. Vernon Sondak. Each pilot project will have three reviewers, a primary reviewer, a secondary reviewer, and a statistical reviewer. The three reviewers will be asked to assign priority scores from 1.0 to 9.0 to the project using the NIH scoring system. Projects from investigators new to cutaneous oncology will be given a high priority.

该发展研究计划（DRP）将通过莫菲特研究人员提出的试点项目的资助来促进对翻译皮肤恶性肿瘤研究的创新思想的探索；它不会支持现有完整项目的扩展。 Vernon Sondak博士将领导DRP。他曾是NCI小组委员会G（培训补助金）的成员，并且是佛罗里达州授予的第一笔批准的首席调查员。他指导了数十名外科肿瘤学家，并被称为杰出导师。为了最大程度地提高资助项目的可能性，如果需要，DRP将支持建立新的合作，并促进另一个相关领域的才华横溢的研究者，即一名新的皮肤肿瘤学研究者，是一名皮肤肿瘤学的新调查员，以使皮肤恶性研究或促进皮肤病的早期研究或已建立了调查员的现象。 DRP的创新特征是，将鼓励调查人员提出项目，虽然总部位于莫菲特，但可能涉及与另一个皮肤孢子机构的既定皮肤孢子项目的合作，或与现有的莫菲特肺孢子合作。与Moffitt肺孢子合作，每年最多一个DRP奖项将由皮肤孢子作为跨孢子互动而共同支持。鼓励与正在进行的Moffitt Skin Spore项目链接的DRP项目。 DRP将为每年最多三个试点项目提供指导，建议，评估和资金。每个试点项目的目标是在预防皮肤恶性肿瘤，治疗，基础研究或应用研究领域中产生足够的高质量数据，以允许向NIH或其他联邦联邦机构提交一个独立的项目以进行同行审查资金。此外，如果现有的完整项目已完成，或者未能满足皮肤孢子外部咨询委员会（EAB）与该皮肤孢子的领导结合，则发展项目可以作为潜在的替代项目提升到完整项目状态的潜在替代项目。奖励评估委员会（AEC）选择DRP项目的资金项目将在NIH研究部分审查过程之后进行建模。 AEC将担任弗农·桑多克（Vernon Sondak）博士。每个试点项目将有三位审阅者，一名主要审阅者，一名二级审阅者和统计审稿人。将要求三位审阅者使用NIH评分系统将优先分数从1.0到9.0分配给项目。来自新手到皮肤肿瘤学的项目将被列出很高的优先事项。